| Subject: | FDA Announces Labeling Change for Dexferrum (Iron Dextran Injection) |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 16 Oct 2009 - 11:00 am |
| Audience: Hematological healthcare professionals, hospital risk managers The Food and Drug Administration (FDA) and American Regent have notified healthcare professionals that anaphylactic-type reactions, including fatalities, have followed the parenteral administration of iron dextran injection. Due to this, the Boxed Warning for Dexferrum (Iron Dextran Injection) has been modified to recommend administering a test dose prior to the first therapeutic dose and observing for signs or symptoms of... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
